We Are Unleashing the Power of microRNA Therapeutics
Regulus is the leading company in the field of microRNA therapeutics. Regulus is advancing microRNA therapeutics across several key areas, including oncology, fibrosis, hepatitis C (HCV) infection and metabolic diseases.
Regulus is located in La Jolla, California, and is led by a seasoned executive team with proven expertise in corporate management, business operations, scientific and drug discovery and drug development.
Regulus provides a competitive benefits package that includes a choice of health, vision, and dental insurance, life insurance, flexible spending accounts, 401K plan, vacation, and stock options.
Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is uniquely positioned to leverage a mature therapeutic platform that harnesses the oligonucleotide drug discovery and development expertise of Alnylam Pharmaceuticals, Inc. … more